Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine in Gastric Endoscopic Submucosal Dissection
NCT04032119Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial of epinephrine in gastric cancer (GC), sponsored by The Chinese University of Hong Kong. Primary endpoint: Overall procedural time. Started Jan 2020; status: completed.
02
Drugs
epinephrine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04032119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04032119.